LobbyingAlliance for Aging Research lobbying by quarter
Alliance for Aging Research's latest lobbying report covers Q2 2026, at $120K. The four quarters Q4 2025–Q3 2026 total $370K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Alliance for Aging Research
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $370K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 2 |
| Q1 2023 | $60K | 2 |
| Q2 2023 | $60K | 2 |
| Q3 2023 | $60K | 2 |
| Q4 2023 | $60K | 2 |
| Q1 2024 | $210K | 3 |
| Q2 2024 | $230K | 3 |
| Q3 2024 | $230K | 3 |
| Q4 2024 | $240K | 3 |
| Q1 2025 | $250K | 3 |
| Q2 2025 | $250K | 3 |
| Q3 2025 | $240K | 3 |
| Q4 2025 | $140K | 3 |
| Q1 2026 | $110K | 3 |
| Q2 2026 | $120K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.2M · 29 reports
- Medicare and Medicaid$695K · 23 reports
- Budget and appropriations$355K · 14 reports
- Trade$30K · 1 reports
- Medical research and clinical labs$0 · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES37 reports
- SENATE36 reports
- Centers For Medicare and Medicaid Services (CMS)27 reports
- Health & Human Services, Dept of (HHS)22 reports
- Executive Office of the President (EOP)9 reports
- Food & Drug Administration (FDA)9 reports
- Centers For Disease Control & Prevention (CDC)4 reports
- Natl Institutes of Health (NIH)3 reports
- Agency for Healthcare Research & Quality (AHRQ)2 reports
- Commerce, Dept of (DOC)1 reports
- Social Security Administration (SSA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAlliance for Aging Research | $1M | 15 quarters |
| Venable | $950K | 15 quarters |
| Akin Gump Strauss Hauer & Feld | $340K | 10 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| SCOTT FREY | Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy | Q2 2026 |
| CAROLINE OLSEN | Director of Member Services, House Republican Conference; Chief of Staff, Rep. Pete Sessions; Communications Director, Rep. Pete Sessions; Press Secretary, Rep. Pete Sessions; Press Assistant, Rep. Pete Sessions; Comms Director, House Rules Committee | Q2 2025 |
| KANDIS MCCLURE | Intern for Sen. Harry Reid, Jan. - Apr. 2013. | Q1 2025 |
| JOCELYN WILES | Staffer, Rep. Kathy Castor (Jan. 07 - Feb. 11); Intern/Fellow, Rep. Barbara Lee (2006); Intern, Rep. Danny Davis (2004). | Q4 2024 |
| SHAWN MAREE BISHOP | Chief Health Advisor, US Sen. Finance Comm. (2/16/21-11/15/2024); Senior Advisor, US Sen. Finance Comm. (5/6/19 - 10/1/19); Professional Staff, US Sen. Finance Comm. (2/5/2005-10/1/2010). | Q4 2024 |
| MIA HECK | Confidential Asst. to Asst. Sec Pub. Affairs, ASPA, HHS (9/02 - 3/04), Dir. Special Proj., IOS, HHS (1/05 - 2/06), Snr Adv. to Administrator, CMS, HHS (10/17 - 1/18), Snr Adv., IEA, HHS (1/18 - 6/19), Dir. External Affairs, OASH, HSS (6/19-1/21) | Q2 2024 |
| YARDLY POLLAS-KIMBLE | Chief of Staff, Deputy Chief of Staff, Legislative Director, Rep. Bobby Rush | Q2 2024 |
| JOHN V. DRZEWICKI | Staff assistant, Rep. Steve Austria; Policy Advisor, US House of Representatives; Policy Director, US House of Representatives | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 09/24for Q2 | In-house | $70K |
| 07/20for Q2 | Venable | $50K |
| 07/20for Q2 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 07/16for Q2 | In-house | $70K |
| 07/16for Q2 | In-house | $70K |
| 04/20for Q1 | In-house | $60K |
| 04/20for Q1 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 04/03for Q1 | Venable | $50K |
| 01/20for Q4 2025 | In-house | $60K |
| 01/20for Q4 2025 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 01/06for Q4 2025 | Venable | $80K |
| 25/11/05for Q3 2025 | In-house | $110K |
| 25/10/20for Q3 2025 | Akin Gump Strauss Hauer & Feld | $50K |
| 25/10/07for Q3 2025 | Venable | $80K |
| 25/07/21for Q2 2025 | Akin Gump Strauss Hauer & Feld | $50K |
| 25/07/21for Q2 2025 | In-house | $120K |
| 25/07/16for Q1 2025 | In-house | $120K |
| 25/07/03for Q2 2025 | Venable | $80K |
| 25/04/21for Q1 2025 | Akin Gump Strauss Hauer & Feld | $50K |
| 25/04/20for Q1 2025 | In-house | $120K |